(Q55059358)

16 June 2018

title

Compendium of FAM46C gene mutations in plasma cell dyscrasias. (English)

1 reference

16 June 2018

author

Pellegrino Musto

7

1 reference

16 June 2018

Luca Baldini

9

1 reference

16 June 2018

Marzia Barbieri

Marzia Barbieri

1

0 references

Martina Manzoni

Martina Manzoni

2

0 references

Agostino Cortelezzi

Agostino Cortelezzi

8

0 references

Antonino Neri

Antonino Neri

10

0 references

Katia Todoerti

5

Katia Todoerti

1 reference

16 June 2018

Marta Lionetti

11

Marta Lionetti

1 reference

16 June 2018

Vittorio Simeon

6

Vittorio Simeon

1 reference

16 June 2018

Gabriella Ciceri

4

Gabriella Ciceri

1 reference

16 June 2018

author name string

Sonia Fabris

3

1 reference

16 June 2018

language of work or name

English

0 references

publication date

12 October 2015

1 reference

16 June 2018

British Journal of Haematology

published in

1 reference

16 June 2018

volume

174

1 reference

16 June 2018

page(s)

642-645

1 reference

16 June 2018

issue

4

1 reference

16 June 2018

A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect.

cites work

1 reference

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

21 January 2018

1 reference

Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.

21 January 2018

1 reference

Initial genome sequencing and analysis of multiple myeloma

21 January 2018

1 reference

Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P).

21 January 2018

1 reference

A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias.

21 January 2018

1 reference

Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy

21 January 2018

1 reference

Translation factors and ribosomal proteins control tumor onset and progression: how?

21 January 2018

1 reference

Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma.

21 January 2018

1 reference

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.13793

1 reference

16 June 2018

PubMed ID

26456599

1 reference

16 June 2018